Enfield, NH, United States of America

Michael Molloy

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael Molloy: Innovator in Anti-Human VISTA Antibodies

Introduction

Michael Molloy is a notable inventor based in Enfield, NH (US), recognized for his contributions to the field of immunology. He holds a total of 5 patents, showcasing his innovative approach to enhancing T cell immunity through the development of anti-human VISTA antibodies.

Latest Patents

Molloy's latest patents include groundbreaking inventions related to anti-human VISTA antibodies and their applications. These inventions provide both antagonistic and agonistic anti-human VISTA antibodies and antibody fragments. The antagonist antibodies are designed to inhibit or block VISTA's suppressive effects on T cell immunity, promoting T cell immunity, which is particularly beneficial in treating cancer and infectious conditions. Conversely, the agonist antibodies are intended to enhance or mimic VISTA's suppressive effects, thereby suppressing T cell immunity, which can be useful in treating autoimmunity, allergies, inflammatory conditions, graft-versus-host disease (GVHD), sepsis, and transplant recipients. Additionally, screening assays for identifying these agonists are included in his patents.

Career Highlights

Throughout his career, Michael Molloy has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Immunex Corporation and Janssen Pharmaceutica NV, where he has contributed significantly to research and development in immunotherapy.

Collaborations

Molloy has collaborated with esteemed colleagues such as Jay Rothstein and Linda Snyder, further enhancing the impact of his work in the field of immunology.

Conclusion

Michael Molloy's innovative work in the development of anti-human VISTA antibodies has the potential to significantly advance treatments for various medical conditions. His contributions reflect a commitment to improving T cell immunity and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…